Puma has returned to the trajectory it was on before the COVID-19 pandemic hit.
Puma has returned to the trajectory it was on before the COVID-19 pandemic hit, reporting that revenues leaped 95.8 percent in the second quarter to 1.59 billion euros, and upgrading its outlook for the rest of the year.
Compared to 2019, the last “normal” year for clothing and footwear sales before the health crisis and retail shutdowns began, first-half revenues advanced over 30 percent. The company upgraded its outlook and predicted growth of around 20 percent for the whole year. Previously it had forecast increases in the mid-teens.
Brasil Últimas Notícias, Brasil Manchetes
Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.
Volkswagen posts record first-half earnings and raises profit margin targetVolkswagen posted record first-half earnings on Thursday while also raising its target for profit margin.
Consulte Mais informação »
3M raises annual forecasts on pandemic recovery, warns of higher costs3M Co (MMM.N) reported a better-than-expected quarterly profit and raised its full-year forecasts, helped by increased demand across major segments as economies recover from the impact of the COVID-19 pandemic.
Consulte Mais informação »
Intense heat raises the risk of violence in American prisonsAdvocates of prison reform argue that housing inmates in facilities without air conditioning violates the Eighth Amendment, which prohibits “cruel and unusual punishments”
Consulte Mais informação »
Oil giant Shell raises dividend and launches $2 billion share buyback as commodity prices soarShell boosted its dividend for the second consecutive quarter and announced the launch of a $2 billion share buyback program.
Consulte Mais informação »
Nissan raises earnings outlook, optimistic chip crunch will easeJapanese automaker Nissan Motor Co (7201.T) on Wednesday raised its earnings outlook for the year, helped by a weaker yen and favourable demand in the United States and China, after reporting a surprise first-quarter operating profit.
Consulte Mais informação »
Pfizer Raises Full-Year Outlook on Covid-19 Vaccine SalesThe pharmaceutical company’s Covid-19 vaccine co-developed with BioNTech contributed $7.8 billion to Pfizer’s total sales of $18.98 billion in the latest quarter.
Consulte Mais informação »